Masimo Corp
NASDAQ:MASI

Watchlist Manager
Masimo Corp Logo
Masimo Corp
NASDAQ:MASI
Watchlist
Price: 137.4 USD -0.68% Market Closed
Market Cap: 7.4B USD

Masimo Corp
Net Income (Common)

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Masimo Corp
Net Income (Common) Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Net Income (Common) CAGR 3Y CAGR 5Y CAGR 10Y
Masimo Corp
NASDAQ:MASI
Net Income (Common)
-$569.4m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Becton Dickinson and Co
NYSE:BDX
Net Income (Common)
$1.7B
CAGR 3-Years
0%
CAGR 5-Years
17%
CAGR 10-Years
9%
Boston Scientific Corp
NYSE:BSX
Net Income (Common)
$2.8B
CAGR 3-Years
67%
CAGR 5-Years
-5%
CAGR 10-Years
N/A
Stryker Corp
NYSE:SYK
Net Income (Common)
$2.9B
CAGR 3-Years
6%
CAGR 5-Years
11%
CAGR 10-Years
10%
Abbott Laboratories
NYSE:ABT
Net Income (Common)
$14B
CAGR 3-Years
21%
CAGR 5-Years
33%
CAGR 10-Years
12%
Intuitive Surgical Inc
NASDAQ:ISRG
Net Income (Common)
$2.7B
CAGR 3-Years
26%
CAGR 5-Years
21%
CAGR 10-Years
18%
No Stocks Found

Masimo Corp
Glance View

Masimo Corp., a pioneering force in noninvasive monitoring technologies, was founded in 1989 by Joe Kiani, who envisioned a healthcare landscape imbued with precision and accessibility. The company rose to prominence with its innovative pulse oximetry technology, a tool crucial for measuring oxygen levels in patients' blood. Unlike traditional methods, Masimo's technology utilizes proprietary signal extraction techniques that allow it to deliver accurate readings even in challenging conditions such as movement or low perfusion. This innovation not only revolutionized patient monitoring but also secured Masimo significant market share within hospitals and healthcare facilities worldwide. Their devices, known for their reliability, feed into a recurring revenue model, as hospitals and medical professionals constantly require new sensors and related consumables to operate the equipment effectively. In addition to pulse oximetry, Masimo has skillfully expanded its portfolio to encompass advanced monitoring systems such as those measuring brain function and hydration levels, offering a comprehensive suite of solutions for enhanced patient care. They have ventured into consumer health as well, with devices that allow people to monitor their health metrics at home. This broadening of scope positions Masimo as a versatile player across both professional and consumer markets. By continually investing in research and development, Masimo aims to address unmet clinical needs and open new revenue streams, thus sustaining its growth trajectory in the competitive landscape of medical technology. Through strategic partnerships and acquisitions, the company has consistently augmented its capabilities, solidifying a robust financial performance anchored in its commitment to innovation and quality.

MASI Intrinsic Value
133.79 USD
Overvaluation 3%
Intrinsic Value
Price

See Also

What is Masimo Corp's Net Income (Common)?
Net Income (Common)
-569.4m USD

Based on the financial report for Sep 27, 2025, Masimo Corp's Net Income (Common) amounts to -569.4m USD.

Back to Top